A Vanderbilt study is testing drugs that provide a targeted fluorescent dye that clings to and illuminates cancer.

Vanderbilt has created a command center charged with identifying and eliminating capacity constraints throughout the health system that could limit the ability to consistently serve all patients in a timely and equitable manner.

“Last Chance Transplant,” the docuseries filmed at Vanderbilt in conjunction with 44 Blue Productions and Rock’n Robins Productions, received the 2022 Inspire Award on Thursday, Aug. 25, from Donate Life Hollywood.

Pablo Juárez, MEd, BCBA, LBA, has been named director of behavior analysis within the Vanderbilt Kennedy Center and the Division of Developmental Medicine at Vanderbilt University Medical Center.

Rarely fatal, the mpox virus — spread by close, often skin-to-skin contact — causes a painful, blistering rash, fever, chills and other symptoms.

Vanderbilt is one of 16 North American sites conducting the Tolerance Using Plasmid in People with Type 1 Diabetes (TOPPLE) study, a phase 1 investigation that tests the safety and dosing of a new plasmid therapy.

New Vanderbilt research could inform therapeutic strategies for enhancing thymic function when desired — such as during aging, recovery from radiation therapy or chemotherapy, or other conditions that reduce T cell output.